Citation Impact

Citing Papers

Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences
2009 StandoutScience
Sinus Microbiome Diversity Depletion and Corynebacterium tuberculostearicum Enrichment Mediates Rhinosinusitis
2012
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Enhancement of hepatitis C virus replication by Epstein-Barr virus-encoded nuclear antigen 1
1999
Gastric cancer
2016 Standout
Epstein–Barr virus—associated gastric carcinomas: Relation to H. pylori infection and genetic alterations
2000
The DNA-damage response in human biology and disease
2009 StandoutNature
Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma
2002
An Epidemiological and Molecular Study of the Relationship Between Smoking, Risk of Nasopharyngeal Carcinoma, and Epstein–Barr Virus Activation
2012
Is Caregiving Hazardous to One's Physical Health? A Meta-Analysis.
2003 Standout
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
Epstein–Barr virus-associated malignancies: epidemiologic patterns and etiologic implications
2000
A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
2010 Standout
The Human Intestinal Microbiome in Health and Disease
2016 Standout
The role of the Epstein-barr virus in human disease
2002
Pathogenic roles for Epstein–Barr virus (EBV) gene products in EBV-associated proliferative disorders
2002
Nasopharyngeal carcinoma
2019 Standout
Detection of Epstein–Barr Virus (EBV) in Hepatocellular Carcinoma Tissue: A Novel EBV Latency Characterized by the Absence of EBV-Encoded Small RNA Expression
1999
The TCL1 family of oncoproteins: co-activators of transformation
2005
Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases
2009
Molecular and cellular pathogenesis of X‐linked lymphoproliferative disease
2005
Control of Germinal Center Responses by T-Follicular Regulatory Cells
2018 StandoutNobel
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Epstein-Barr virus in gastric carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesis
2004
The DNA Damage Response: Making It Safe to Play with Knives
2010 Standout
Novel Roles for MLH3 Deficiency and TLE6-Like Amplification in DNA Mismatch Repair-Deficient Gastrointestinal Tumorigenesis and Progression
2008 StandoutNobel
Etiological factors of nasopharyngeal carcinoma
2014
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
The Pilot Experience of Immunotherapy-Combined Photodynamic Therapy for Advanced Gastric Cancer in Elderly Patients
2002
Epstein-Barr virus-associated gastric adenocarcinoma
2019
Nasopharyngeal carcinoma
2015 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Short Telomeres are Sufficient to Cause the Degenerative Defects Associated with Aging
2009 StandoutNobel
Foxp3+ T Cells Regulate Immunoglobulin A Selection and Facilitate Diversification of Bacterial Species Responsible for Immune Homeostasis
2014
Self-consumption: the interplay of autophagy and apoptosis
2014 Standout
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
2014 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Epstein–Barr virus: 40 years on
2004 Standout
Entry of viruses through the epithelial barrier: pathogenic trickery
2003
Epstein–Barr Virus Infection and Gastric Cancer
2015
Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography
2005
B cells under influence: transformation of B cells by Epstein–Barr virus
2003
Infectious agents and lymphoma development: molecular and clinical aspects
2009
Photodynamic therapy of cancer: An update
2011 Standout
Gastric cancer
2020 Standout
Utilisation of Mucin Glycans by the Human Gut Symbiont Ruminococcus gnavus Is Strain-Dependent
2013
Unmet needs and challenges in gastric cancer: The way forward
2014
Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with epstein-barr virus and anatomic location in the body of the stomach
2000
Ras, PI(3)K and mTOR signalling controls tumour cell growth
2006 StandoutNature
Mucin glycan foraging in the human gut microbiome
2015
Differential inflammatory response to Helicobacter pylori infection: etiology and clinical outcomes
2015
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Twin Study Indicates Loss of Interaction Between Microbiota and Mucosa of Patients With Ulcerative Colitis
2011
Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition
2010
Epstein–Barr Virus Infection
2000 Standout
The human microbiome: at the interface of health and disease
2012 Standout
Replication of hepatitis C virus
2007 StandoutNobel
Downregulation of MicroRNA-200 in EBV-Associated Gastric Carcinoma
2010
Gut Microbiota in Health and Disease
2010 Standout
Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies.
2000
Exosomes
2019 Standout
Epstein-Barr Virus Latent Membrane Protein 2A Regulates c-Jun Protein through Extracellular Signal-Regulated Kinase
2002
Genome-Wide DNA Methylation as an Epigenetic Consequence of Epstein-Barr Virus Infection of Immortalized Keratinocytes
2014
Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review
2008
Identification of Virus-Encoded MicroRNAs
2004 StandoutScience
CD63 Regulates Epstein-Barr Virus LMP1 Exosomal Packaging, Enhancement of Vesicle Production, and Noncanonical NF-κB Signaling
2017
EBV-Positive Gastric Adenocarcinomas: A Distinct Clinicopathologic Entity With a Low Frequency of Lymph Node Involvement
2004
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection
2004 StandoutNobel
Follicular Helper CD4 T Cells (TFH)
2011 Standout
Epstein-Barr Virus-Positive Gastric Carcinoma Has a Distinct Protein Expression Profile in Comparison with Epstein-Barr Virus-Negative Carcinoma
2004
Intestinal microbiota in human health and disease: the impact of probiotics
2011
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
ICOS+Foxp3+TILs in gastric cancer are prognostic markers and effector regulatory T cells associated withHelicobacter pylori
2016 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Introduction to the human gut microbiota
2017 Standout
Transcriptional control of human p53-regulated genes
2008 Standout
Establishment of an oriP Replicon Is Dependent upon an Infrequent, Epigenetic Event
2001
Defective B cell responses in the absence of SH2D1A
2005
Oncogenic Role of Epstein-Barr Virus-Encoded RNAs in Burkitt’s Lymphoma Cell Line Akata
1999
Control of foreign Ag‐specific Ab responses by Treg and Tfr
2020 StandoutNobel
BODIPY dyes in photodynamic therapy
2012 Standout
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Resting B cells as a transfer vehicle for Epstein–Barr virus infection of epithelial cells
2006
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
2008 StandoutNobel
Emerging Targets in Photopharmacology
2016 StandoutNobel
Cellular receptors for viruses: links to tropism and pathogenesis
2000
SPECTRUM OF EPSTEIN-BARR VIRUS–ASSOCIATED DISEASES
2006
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Endoscopic resection (endoscopic mucosal resection/ endoscopic submucosal dissection) for early gastric cancer
2013
Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer
2015

Works of Jun Nishikawa being referenced

Role of DNA methylation in the development of Epstein–Barr virus‐associated gastric carcinoma
2012
Wild-type p53 activates SAP expression in lymphoid cells
2004
Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis
2008
Epstein-Barr Virus-Associated Gastric Carcinoma and Atrophic Gastritis
1999
Clinical impact of strip biopsy for early gastric cancer
2004
The long‐term efficacy of Helicobacter pylori eradication therapy in patients with idiopathic thrombocytopenic purpura
2007
Ulcerous Change Decreases the Accuracy of Endoscopic Ultrasonography Diagnosis for the Invasive Depth of Early Gastric Cancer
2007
SH2D1A expression in Burkitt lymphoma cells is restricted to EBV positive group I lines and is downregulated in parallel with immunoblastic transformation
2002
T cell leukemia I oncogene expression depends on the presence of Epstein–Barr virus in the virus- carrying Burkitt lymphoma lines
2003
Helicobacter pylori CagA inhibits endocytosis of cytotoxin VacA in host cells
2010
Epstein-Barr Virus (EBV)-associated Gastric Carcinoma
2012
Cell-to-Cell Contact as an Efficient Mode of Epstein-Barr Virus Infection of Diverse Human Epithelial Cells
1998
Epstein-Barr Virus Promotes Epithelial Cell Growth in the Absence of EBNA2 and LMP1 Expression
1999
GI Cancer High Prevalence of Epstein-Barr Virus in Gastric Remnant Carcinoma after Billroth-II Reconstruction
2002
Experience with photodynamic therapy (endoscopic laser therapy) for the treatment of early gastric cancer.
2002
Epstein-Barr Virus in Gastric Carcinoma
2014
Rankless by CCL
2026